Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

NimbleGen raises $10.5mm in Series B round

Executive Summary

NimbleGen Systems Inc. (develops high-density DNA arrays) completed a Series B private financing, raising $9mm last month in the first tranche and an additional $1.5mm in a second closing. New investors Venture Investors Management, Baird Venture Partners, and State of Wisconsin Investment Board participated along with returning investors Skyline Ventures, Tactics II Investments, and the Wisconsin Alumni Research Foundation.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register